CA1312080C - Arylpiperazinyl-ethyl(or butyl)-phenyl-heterocyclic compounds - Google Patents
Arylpiperazinyl-ethyl(or butyl)-phenyl-heterocyclic compoundsInfo
- Publication number
- CA1312080C CA1312080C CA000558900A CA558900A CA1312080C CA 1312080 C CA1312080 C CA 1312080C CA 000558900 A CA000558900 A CA 000558900A CA 558900 A CA558900 A CA 558900A CA 1312080 C CA1312080 C CA 1312080C
- Authority
- CA
- Canada
- Prior art keywords
- phenyl
- piperazinyl
- mmol
- ethyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US87/00340 | 1987-02-17 | ||
| US8700340 | 1987-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1312080C true CA1312080C (en) | 1992-12-29 |
Family
ID=22202287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000558900A Expired - Lifetime CA1312080C (en) | 1987-02-17 | 1988-02-15 | Arylpiperazinyl-ethyl(or butyl)-phenyl-heterocyclic compounds |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0279598B1 (enExample) |
| JP (1) | JPH0699405B2 (enExample) |
| KR (1) | KR900004126B1 (enExample) |
| CN (1) | CN1015627B (enExample) |
| AP (1) | AP88A (enExample) |
| AR (1) | AR245125A1 (enExample) |
| AT (1) | ATE94537T1 (enExample) |
| AU (1) | AU583761B2 (enExample) |
| CA (1) | CA1312080C (enExample) |
| CS (1) | CS272783B2 (enExample) |
| DD (1) | DD272080A5 (enExample) |
| DE (1) | DE3884007T2 (enExample) |
| DK (1) | DK170878B1 (enExample) |
| EG (1) | EG18635A (enExample) |
| ES (1) | ES2058249T3 (enExample) |
| FI (1) | FI91752C (enExample) |
| HU (1) | HU207731B (enExample) |
| IE (1) | IE61258B1 (enExample) |
| IL (1) | IL85368A0 (enExample) |
| IN (1) | IN171858B (enExample) |
| MA (1) | MA21183A1 (enExample) |
| MX (1) | MX174210B (enExample) |
| MY (1) | MY103210A (enExample) |
| NO (1) | NO170582C (enExample) |
| NZ (1) | NZ223530A (enExample) |
| PL (1) | PL157118B1 (enExample) |
| PT (1) | PT86766B (enExample) |
| SU (1) | SU1634136A3 (enExample) |
| YU (1) | YU46624B (enExample) |
| ZA (1) | ZA881064B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
| SE8803429D0 (sv) * | 1988-09-28 | 1988-09-28 | Pharmacia Ab | Novel pyridyl- and pyrimidyl derivatives |
| US5162321A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | 1-naphthyl piperazines useful as 5-HT1A receptor ligands |
| US5166157A (en) * | 1989-12-20 | 1992-11-24 | Adir Et Compagnie | Naphthyl piperazines useful as 5-HT1A receptor ligands |
| US5166156A (en) * | 1989-12-20 | 1992-11-24 | Adir Et Compagnie | Naphthyl piperazines useful as 5-HT1A receptor ligands |
| FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5162324A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | Naphyl piperazines useful as 5-HT1A receptor ligands |
| JP3057763B2 (ja) * | 1995-06-06 | 2000-07-04 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 抗精神病薬としてのベンゾイソオキサゾール及びインダゾール誘導体 |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| US6288091B1 (en) | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
| WO1997024343A1 (en) | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenyl thiazole derivatives with anti herpes virus properties |
| WO1999001420A1 (en) * | 1997-07-03 | 1999-01-14 | Taito Co., Ltd. | Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2927924A (en) * | 1958-04-03 | 1960-03-08 | Lilly Co Eli | Novel phenethyl-substituted piperazines |
| GB948766A (en) * | 1959-10-20 | 1964-02-05 | May & Baker Ltd | Trifluoromethylphenylpiperazine derivatives |
| DE1695410A1 (de) * | 1967-04-20 | 1971-04-08 | Merck Patent Gmbh | Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen |
| JPS5910675B2 (ja) * | 1976-03-22 | 1984-03-10 | ウェルファイド株式会社 | アラルキルアミン誘導体 |
| US4411901A (en) * | 1981-12-23 | 1983-10-25 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
| US4619930A (en) * | 1985-01-16 | 1986-10-28 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use |
| JPH075579B2 (ja) * | 1986-09-01 | 1995-01-25 | 吉富製薬株式会社 | アミノチアゾ−ル化合物 |
-
1987
- 1987-02-17 MX MX010428A patent/MX174210B/es unknown
-
1988
- 1988-01-27 IN IN64/DEL/88A patent/IN171858B/en unknown
- 1988-02-09 IL IL85368A patent/IL85368A0/xx not_active IP Right Cessation
- 1988-02-12 AT AT88301171T patent/ATE94537T1/de not_active IP Right Cessation
- 1988-02-12 ES ES88301171T patent/ES2058249T3/es not_active Expired - Lifetime
- 1988-02-12 DE DE88301171T patent/DE3884007T2/de not_active Expired - Fee Related
- 1988-02-12 EP EP88301171A patent/EP0279598B1/en not_active Expired - Lifetime
- 1988-02-13 KR KR1019880001454A patent/KR900004126B1/ko not_active Expired
- 1988-02-15 PL PL1988270653A patent/PL157118B1/pl unknown
- 1988-02-15 MA MA21420A patent/MA21183A1/fr unknown
- 1988-02-15 CA CA000558900A patent/CA1312080C/en not_active Expired - Lifetime
- 1988-02-15 JP JP63032593A patent/JPH0699405B2/ja not_active Expired - Fee Related
- 1988-02-15 PT PT86766A patent/PT86766B/pt not_active IP Right Cessation
- 1988-02-15 CN CN88100986A patent/CN1015627B/zh not_active Expired
- 1988-02-16 IE IE42088A patent/IE61258B1/en not_active IP Right Cessation
- 1988-02-16 MY MYPI88000161A patent/MY103210A/en unknown
- 1988-02-16 CS CS96488A patent/CS272783B2/cs not_active IP Right Cessation
- 1988-02-16 AR AR88310090A patent/AR245125A1/es active
- 1988-02-16 NO NO880667A patent/NO170582C/no not_active IP Right Cessation
- 1988-02-16 ZA ZA881064A patent/ZA881064B/xx unknown
- 1988-02-16 AP APAP/P/1988/000082A patent/AP88A/en active
- 1988-02-16 AU AU11740/88A patent/AU583761B2/en not_active Ceased
- 1988-02-16 YU YU30388A patent/YU46624B/sh unknown
- 1988-02-16 SU SU4355194A patent/SU1634136A3/ru active
- 1988-02-16 HU HU88748A patent/HU207731B/hu unknown
- 1988-02-16 DD DD88312959A patent/DD272080A5/de not_active IP Right Cessation
- 1988-02-16 DK DK078888A patent/DK170878B1/da not_active IP Right Cessation
- 1988-02-16 NZ NZ223530A patent/NZ223530A/xx unknown
- 1988-02-16 FI FI880716A patent/FI91752C/fi active IP Right Grant
- 1988-02-17 EG EG9388A patent/EG18635A/xx active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1302418C (en) | 3,5-disubstituted pyrocatechole derivatives | |
| CA1190224A (en) | Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists | |
| US3017415A (en) | Certain benzimidazoles carrying thiazolyl, thiadiazolyl and isothiazolyl substituents in the 2 position | |
| CA1300139C (en) | Piperazinyl-heterocyclic compounds | |
| US5338846A (en) | Process for preparing aryl piperazinyl-heterocyclic compounds with a piperazine salt | |
| US3843668A (en) | Certain 4-substituted amino-2,1,3-benzothiadiozoles | |
| CA2022731A1 (en) | Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same | |
| EP0279598B1 (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds | |
| US4891375A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds | |
| FI75821C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 2-guanidino-4-heteroaryltiazoler. | |
| EP0557289B1 (en) | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents | |
| DK153950B (da) | Analogifremgangsmaade til fremstilling af quinolylguanidiner eller derivater deraf | |
| US5071864A (en) | Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents containing them | |
| US4940790A (en) | 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6H-1,3,4-thiadiazines | |
| US3992535A (en) | 4-Hydroxy-2H-naphtho[2,1-e]-1,2-thiazine-3-carboxamide-1,1-dioxides and salts thereof | |
| CA2111442A1 (en) | Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof | |
| JPS6136755B2 (enExample) | ||
| US4112092A (en) | 1-Naphthylmethyl-4-(thiazolyl-2)-piperazines | |
| DK156059B (da) | Analogifremgangsmaade til fremstilling af guanidinderivater | |
| CA1175827A (en) | 5-aminomethyl-2,3-dihydro-2-oxo-1h-imidazole-4- carboxylic acid derivatives | |
| NZ234487A (en) | Substituted 2-imino-3-alkylbenzothiazolines, preparation and pharmaceutical compositions thereof | |
| CA1267412A (en) | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity | |
| JPS61115074A (ja) | ３，４‐ジアゾール誘導体、その製法、およびその化合物を含有する医薬品 | |
| US3299080A (en) | Processes and intermediates for preparing certain 2-thiazolylbenzimidazoles | |
| NZ202780A (en) | N,n-disubstituted alkenamides and phenylalkenamides and pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |